GetTopicDetailResponse(id=66f51e0207d, topicName=T-LBL, introduction=T-LBL, content=null, image=null, comments=1, allHits=600, url=https://h5.medsci.cn/topic?id=17020, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99811, tagList=[TagDto(tagId=99811, tagName=T-LBL)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2201567, encodeId=1f04220156eb1, content=<a href='/topic/show?id=66f51e0207d' target=_blank style='color:#2F92EE;'>#T-LBL#</a> <a href='/topic/show?id=f52111406391' target=_blank style='color:#2F92EE;'>#T淋巴母細(xì)胞淋巴瘤#</a>, objectTitle=【BJH】異基因造血干細(xì)胞移植治療成人T淋巴母細(xì)胞淋巴瘤的中國(guó)真實(shí)世界研究, objectType=article, longId=824138, objectId=6f558241386b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=6f558241386b, replyNumber=0, likeNumber=69, createdTime=2024-05-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6f558241386b, moduleTitle=【BJH】異基因造血干細(xì)胞移植治療成人T淋巴母細(xì)胞淋巴瘤的中國(guó)真實(shí)世界研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=6f558241386b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1795635, encodeId=e04a1e95635b0, content=<a href='/topic/show?id=66f51e0207d' target=_blank style='color:#2F92EE;'>#T-LBL#</a>, objectTitle=Blood：PIM抑制或可改善IL7反應(yīng)性CD127+ T-ALL和T-LBL患者化療預(yù)后, objectType=article, longId=188248, objectId=167e18824812, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=167e18824812, replyNumber=0, likeNumber=112, createdTime=2020-03-04, rootId=0, userName=lqrandywkz, userId=86b7385, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=167e18824812, moduleTitle=Blood：PIM抑制或可改善IL7反應(yīng)性CD127+ T-ALL和T-LBL患者化療預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=167e18824812)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
